Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

The earnings call presents a mixed picture. Positive elements include strategic M&A plans, new facility investments, and a share buyback program, indicating confidence. However, challenges such as payer mix issues, slow revenue growth, and cautious guidance offset these positives. The Q&A reveals management's plans to address these challenges, but uncertainty remains. Given the company's market cap and the balance of positive and negative factors, the stock price is likely to remain stable in the short term, resulting in a neutral rating.
The earnings call presents mixed signals. Strong growth in orthopedic procedures and revenue guidance reaffirmation are positive. However, weaker-than-expected demand, a reduction in acquisition spending, and a $20 million EBITDA guidance cut are concerning. Management's uncertainty about macroeconomic factors and payer mix changes adds to the ambiguity. The market cap suggests moderate sensitivity, leading to a neutral prediction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.